Sanara MedTech Inc. SMTI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -211.66% | -198.67% | 128.51% | 94.71% | -1,409.69% |
| Total Depreciation and Amortization | -0.99% | 5.41% | -12.13% | 9.41% | -11.27% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -6.58% | 22.61% | -56.43% | -85.13% | 810.30% |
| Change in Net Operating Assets | 538.49% | 89.93% | -1,448.76% | -82.10% | 244.39% |
| Cash from Operations | 91.53% | 182.68% | -162.49% | 81.27% | -18.30% |
| Capital Expenditure | 100.00% | 87.90% | 46.72% | 92.24% | 39.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -887.92% | 88.96% |
| Cash from Investing | -33,075.47% | 87.90% | 98.21% | 28.52% | 12.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -277.48% | 56.54% | -440.89% | 117.99% | 68.57% |
| Cash from Financing | -277.48% | 56.54% | -440.89% | 117.99% | 68.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.19% | 161.21% | -282.06% | 181.18% | 45.86% |